New Drug Approvals Archive
Get news by email or subscribe to our news feeds.
July 2002
| October 16 |
Elitek (rasburicase)
Patient Population Altered: October 16, 2009 |
 |
 |
FDA Consumer Updates
Recently Approved
- Mekinist Mekinist (trametinib) is a kinase inhibitor indicated for the treatment of patients with unresectable or...
- Tafinlar Tafinlar (dabrafenib) is a kinase inhibitor indicated for the treatment of patients with unresectable or...
- Xofigo Xofigo (radium 223 dichloride) is an alpha particle-emitting radioactive therapeutic agent indicated for...
- Nymalize Nymalize (nimodipine) is a calcium channel blocker indicated to improve neurological outcome following...
- Breo Ellipta Breo Ellipta (fluticasone and vilanterol) is a once-a-day inhaled corticosteroid / long-acting beta2 agonist...
Get Updates by Email
Email me:
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated May 17th, 2013), Cerner Multum™ (updated May 20th, 2013), Wolters Kluwer™ (updated Apr 30th, 2013) and others. To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2013 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here